These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20640405)

  • 1. Neuropsychological deficits in adolescent methamphetamine abusers.
    King G; Alicata D; Cloak C; Chang L
    Psychopharmacology (Berl); 2010 Oct; 212(2):243-9. PubMed ID: 20640405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.
    Mahoney JJ; Jackson BJ; Kalechstein AD; De La Garza R; Newton TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):459-65. PubMed ID: 21122811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina.
    Price KL; DeSantis SM; Simpson AN; Tolliver BK; McRae-Clark AL; Saladin ME; Baker NL; Wagner MT; Brady KT
    Am J Addict; 2011; 20(5):447-55. PubMed ID: 21838844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence.
    Simon SL; Dean AC; Cordova X; Monterosso JR; London ED
    J Stud Alcohol Drugs; 2010 May; 71(3):335-44. PubMed ID: 20409426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.
    Kalechstein AD; Newton TF; Green M
    J Neuropsychiatry Clin Neurosci; 2003; 15(2):215-20. PubMed ID: 12724464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
    Chen YC; Wang LJ; Lin SK; Chen CK
    Subst Use Misuse; 2015; 50(14):1778-85. PubMed ID: 26625283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls.
    Wang LJ; Chen CK; Lin SK; Chen YC; Xu K; Huang MC
    Psychopharmacology (Berl); 2018 Jul; 235(7):2113-2121. PubMed ID: 29713787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
    McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA
    Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairments of facial emotion recognition and theory of mind in methamphetamine abusers.
    Kim YT; Kwon DH; Chang Y
    Psychiatry Res; 2011 Mar; 186(1):80-4. PubMed ID: 20643485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of HIV infection, antiretroviral therapy, and immune status on the speed of information processing and complex motor functions in adult Cameroonians.
    Kanmogne GD; Fonsah JY; Umlauf A; Moul J; Doh RF; Kengne AM; Tang B; Tagny CT; Nchindap E; Kenmogne L; Franklin D; Njamnshi DM; Kuate CT; Mbanya D; Njamnshi AK; Heaton RK
    Sci Rep; 2020 Aug; 10(1):14016. PubMed ID: 32820234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Testing of a Smartphone-Based Cognitive/Neuropsychological Evaluation System for Substance Abusers.
    Pal R; Mendelson J; Clavier O; Baggott MJ; Coyle J; Galloway GP
    J Psychoactive Drugs; 2016; 48(4):288-94. PubMed ID: 27260123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
    Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of learning, memory, and executive function in new MDMA users.
    Wagner D; Becker B; Koester P; Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2013 Jan; 108(1):136-45. PubMed ID: 22831704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice.
    Kesby JP; Heaton RK; Young JW; Umlauf A; Woods SP; Letendre SL; Markou A; Grant I; Semenova S
    Neuropsychopharmacology; 2015 Jul; 40(8):1899-909. PubMed ID: 25652249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Executive dysfunction in patients with temporal lobe epilepsy and its correlation with P300].
    Yao X; Yu Q; Yang E; Ouyang H; Chen Y; Yang W; Chen Z; Wang Z
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(7):521-4. PubMed ID: 24767295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between serum brain-derived neurotrophic level and neurocognitive functions in chronic methamphetamine users.
    Moaveni A; Fayaz Feyzi Y; Tayebeh Rahideh S; Arezoomandan R
    Neurosci Lett; 2022 Feb; 772():136478. PubMed ID: 35085693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.